Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern

Cho, H., Gonzales-Wartz, K. K., Huang, D., Yuan M., Peterson, M., Liang, J., Beutler, N., Torres, J. L., Cong, Y., Postnikova, E., Bangaru, S., Talana, C. A., Shi, W., Yang, E. S., Zhang, Y., Leung, K., Wang, L., Peng, L., Skinner, J., Li, S., Wu, N. C., Liu, H., Dacon, C., Moyer,T., Cohen, M., Zhao, M., Lee, F. E., Weinberg, R. S.,Douagi, I., Gross, R., Schmaljohn, C., Pegu, A., Mascola, J. R., Holbrook, M., Nemazee, D., Rogers, T. F.,Ward, A. B., Wilson, I. A., Crompton, P. D., Tan, J.  Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.  Sci. Transl. Med. 2021.  doi: 10.1126/scitranslmed.abj5413

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.